CoChat

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Invasive fungal infection (IFI) is a leading cause of infection-related mortality among patients with cancer and prolonged neutropenia and among allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Invasive candidiasis was the principal IFI in the period predating fluconazole prophylaxis, whereas today, invasive aspergillosis and other mold infections cause the majority of deaths from fungal infection in this patient population. The changing epidemiology of IFI, in addition to advances made in antifungal therapeutics and early diagnosis of IFI, warrant a reevaluation of earlier strategies aimed at prevention and early treatment of IFI that were developed several years ago. Here, we propose that persistent neutropenic fever is nonspecific for an IFI and should not be used as the sole criterion for empirical modification in the antifungal regimen in a patient receiving mold-active prophylaxis. We explore the potential benefits and gaps in knowledge associated with employing chest CT scans and laboratory markers as diagnostic adjuncts for IFI. Finally, we discuss the implications of newer antifungal agents and diagnostic adjuncts in the design of future clinical trials to evaluate prophylaxis and early prevention strategies.

Overview

Integrity signals

Registry

Crossref · 10.1086/510677

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 79 references

Research works printed but not linked: 5

  1. AISNER, 1977, Annals of Internal Medicine, 86, 539, 10.1059/0003-4819-86-5-539 · doi:10.1059/0003-4819-86-5-539
  2. -1, Journal of Infectious Diseases, -1, MASTER, 10.1093/jnlids/171.6.1545 · doi:10.1093/jnlids/171.6.1545
  3. Marr, 2004, Current opinion in investigational drugs (London, England : 2000), 5, 202
  4. 2003, Blood, 2, 2
  5. 2003, Blood, 22, 22

Cited by

See all 168

Metadata

Authors
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R.
Affiliations
  • Roswell Park Comprehensive Cancer Center (US)
  • Hôpitaux Universitaires de Strasbourg (FR)
  • Duke Medical Center (US)
  • National Institutes of Health (US)
  • University of Florida (US)
Corresponding author
Segal, B. H.
Venue
Clinical Infectious Diseases
Published
2007-02-01
Volume
44
Issue
3
Pages
402-409
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2134986902
Cited by
168
References
77
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 10 · 2012: 8
FWCI
16.36
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
invasive fungal infections, invasive candidiasis, invasive aspergillosis, mold infections, cancer patients, neutropenia, hematopoietic stem cell transplantation, graft-versus-host disease, antifungal prophylaxis, fluconazole, chest CT, laboratory biomarkers, early diagnosis, antifungal agents, clinical trial design
MeSH terms
Antifungal Agents, Evaluation Studies as Topic, Fever, Fungi, Galactose, Humans, Mannans, Mycoses, Neoplasms, Neutropenia, Tomography, X-Ray Computed, Yeasts, Biomarkers, Randomized Controlled Trials as Topic, Practice Guidelines as Topic, Hematopoietic Stem Cell Transplantation, beta-Glucans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. https://app.cochat.ai/papers/10.1086/510677
The paper
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007). Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clinical Infectious Diseases. https://doi.org/10.1086/510677

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.